Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
Sagun Parakh(Australian Research Council), Ashleigh R. Poh(La Trobe University)
Cited by 65
Related Papers
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
|Journal of Clinical Oncology|2024|177
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
|Journal of Clinical Oncology|2024|137
Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis
|Cell Reports|2022|20